Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma

    August 2016 in “ ˜The œoncologist
    Mario E. Lacouture, Brigitte Dréno, Paolo A. Ascierto, Reinhard Dummer, Nicole Basset-Séguin, Kate Fife, Scott Ernst, Lisa Licitra, Rogerio I. Neves, Ketty Peris, Susana Puig, Jonas Sokolof, Aleksandar Sekulić, Axel Hauschild, Rainer Kunstfeld
    TLDR Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.
    The document reviewed the adverse events associated with Hedgehog pathway inhibitors (HPIs) in patients with advanced basal cell carcinoma (BCC), focusing on common side effects like muscle spasms, dysgeusia, alopecia, weight loss, and fatigue. These side effects, often mild to moderate but persistent, necessitated effective management strategies such as dose adjustments, supportive care, and patient education to improve adherence and quality of life. The study emphasized the importance of managing these adverse events to ensure patients could continue benefiting from HPI therapy, with specific strategies for each type of side effect, including dietary adjustments, nutritional support, and physical and psychosocial interventions.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 19 results

    Similar Research

    5 / 1000+ results